Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hepacivirus | 82 | 2023 | 1379 | 7.640 |
Why?
|
Hepatitis C | 81 | 2023 | 1591 | 6.630 |
Why?
|
CD8-Positive T-Lymphocytes | 42 | 2023 | 4479 | 3.010 |
Why?
|
Hepatitis C, Chronic | 25 | 2023 | 1031 | 2.490 |
Why?
|
Hepatitis B, Chronic | 8 | 2023 | 393 | 1.960 |
Why?
|
CD4-Positive T-Lymphocytes | 19 | 2022 | 4386 | 1.940 |
Why?
|
Hepatitis B | 6 | 2023 | 695 | 1.450 |
Why?
|
Hepatitis B virus | 8 | 2023 | 513 | 1.350 |
Why?
|
Substance Abuse, Intravenous | 11 | 2020 | 525 | 1.100 |
Why?
|
Immunologic Memory | 6 | 2021 | 1348 | 0.820 |
Why?
|
Antiviral Agents | 16 | 2023 | 2987 | 0.800 |
Why?
|
Epitopes, T-Lymphocyte | 21 | 2019 | 880 | 0.780 |
Why?
|
Viral Nonstructural Proteins | 13 | 2016 | 241 | 0.690 |
Why?
|
HLA-B Antigens | 5 | 2017 | 354 | 0.660 |
Why?
|
Viral Vaccines | 4 | 2014 | 636 | 0.650 |
Why?
|
Epitopes | 5 | 2021 | 2571 | 0.640 |
Why?
|
Hepatitis A | 1 | 2019 | 133 | 0.640 |
Why?
|
Hepatitis C Antibodies | 8 | 2019 | 145 | 0.630 |
Why?
|
Gastroenterology | 1 | 2022 | 538 | 0.550 |
Why?
|
Virus Replication | 7 | 2023 | 2535 | 0.530 |
Why?
|
RNA, Viral | 17 | 2022 | 2901 | 0.520 |
Why?
|
Acute Disease | 18 | 2022 | 7147 | 0.500 |
Why?
|
Transcription, Genetic | 3 | 2019 | 7721 | 0.490 |
Why?
|
Liver | 12 | 2024 | 7475 | 0.450 |
Why?
|
Interferons | 8 | 2020 | 706 | 0.430 |
Why?
|
Plastic Embedding | 2 | 2009 | 8 | 0.420 |
Why?
|
T-Lymphocytes | 7 | 2019 | 10183 | 0.400 |
Why?
|
Flow Cytometry | 4 | 2019 | 5974 | 0.400 |
Why?
|
Lymphocyte Activation | 11 | 2022 | 5524 | 0.400 |
Why?
|
Interleukins | 5 | 2018 | 791 | 0.390 |
Why?
|
Haplotypes | 2 | 2020 | 2779 | 0.380 |
Why?
|
Antigens, CD | 6 | 2022 | 4026 | 0.370 |
Why?
|
Remission, Spontaneous | 8 | 2022 | 382 | 0.370 |
Why?
|
Genome, Viral | 6 | 2019 | 667 | 0.350 |
Why?
|
Viral Hepatitis Vaccines | 5 | 2019 | 80 | 0.340 |
Why?
|
Paraffin Embedding | 1 | 2009 | 299 | 0.330 |
Why?
|
Immunodominant Epitopes | 5 | 2015 | 267 | 0.320 |
Why?
|
Killer Cells, Natural | 4 | 2019 | 2133 | 0.310 |
Why?
|
Lectins, C-Type | 4 | 2022 | 589 | 0.310 |
Why?
|
Prisoners | 2 | 2013 | 297 | 0.310 |
Why?
|
Genotype | 18 | 2022 | 12952 | 0.310 |
Why?
|
HLA-B27 Antigen | 3 | 2013 | 76 | 0.310 |
Why?
|
Prisons | 1 | 2009 | 161 | 0.290 |
Why?
|
Humans | 126 | 2024 | 744366 | 0.290 |
Why?
|
Antigens, Differentiation | 1 | 2009 | 927 | 0.280 |
Why?
|
T-Box Domain Proteins | 4 | 2016 | 471 | 0.260 |
Why?
|
Disease Transmission, Infectious | 2 | 2019 | 547 | 0.260 |
Why?
|
Immunity, Cellular | 3 | 2007 | 1607 | 0.240 |
Why?
|
Viral Load | 11 | 2022 | 3300 | 0.240 |
Why?
|
Antibodies, Neutralizing | 4 | 2019 | 1978 | 0.230 |
Why?
|
Adaptive Immunity | 2 | 2019 | 714 | 0.230 |
Why?
|
Viremia | 6 | 2012 | 736 | 0.230 |
Why?
|
HIV Infections | 14 | 2023 | 16715 | 0.220 |
Why?
|
Drug Users | 4 | 2019 | 134 | 0.220 |
Why?
|
Phylogeny | 9 | 2019 | 2804 | 0.220 |
Why?
|
Immune Evasion | 2 | 2017 | 360 | 0.220 |
Why?
|
Drug Resistance, Viral | 3 | 2016 | 820 | 0.220 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2007 | 1157 | 0.210 |
Why?
|
Antigens, Surface | 2 | 2022 | 1663 | 0.210 |
Why?
|
Antigens, Viral | 3 | 2021 | 1035 | 0.210 |
Why?
|
Histocompatibility Antigens Class II | 3 | 2019 | 1475 | 0.210 |
Why?
|
Peroxidases | 1 | 2022 | 138 | 0.200 |
Why?
|
Interferon-alpha | 4 | 2019 | 895 | 0.200 |
Why?
|
Lymphocytic Choriomeningitis | 3 | 2016 | 132 | 0.200 |
Why?
|
Hepatitis C Antigens | 3 | 2015 | 34 | 0.200 |
Why?
|
HIV-1 | 6 | 2017 | 6939 | 0.190 |
Why?
|
T-Lymphocyte Subsets | 3 | 2015 | 1837 | 0.190 |
Why?
|
Male | 57 | 2024 | 350115 | 0.190 |
Why?
|
Immunity, Innate | 3 | 2019 | 2962 | 0.190 |
Why?
|
Female | 61 | 2024 | 380193 | 0.190 |
Why?
|
Immunotherapy | 3 | 2016 | 4446 | 0.180 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 2 | 2022 | 906 | 0.180 |
Why?
|
Adult | 46 | 2024 | 214052 | 0.180 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2022 | 15520 | 0.180 |
Why?
|
Liver Cirrhosis | 6 | 2024 | 1862 | 0.180 |
Why?
|
Ribavirin | 4 | 2021 | 395 | 0.180 |
Why?
|
Middle Aged | 34 | 2024 | 213390 | 0.170 |
Why?
|
Histocompatibility Antigens Class I | 3 | 2019 | 1366 | 0.170 |
Why?
|
Phenotype | 6 | 2021 | 16367 | 0.170 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2019 | 73 | 0.170 |
Why?
|
Bone and Bones | 1 | 2009 | 2576 | 0.170 |
Why?
|
T-Cell Antigen Receptor Specificity | 3 | 2015 | 87 | 0.160 |
Why?
|
Natural Killer T-Cells | 1 | 2022 | 316 | 0.160 |
Why?
|
Cell Differentiation | 9 | 2021 | 11486 | 0.160 |
Why?
|
Mouth Mucosa | 1 | 2001 | 434 | 0.160 |
Why?
|
Major Histocompatibility Complex | 2 | 2018 | 936 | 0.160 |
Why?
|
Fatty Liver | 1 | 2024 | 727 | 0.160 |
Why?
|
Receptors, KIR3DL1 | 1 | 2017 | 22 | 0.150 |
Why?
|
Color | 1 | 2019 | 307 | 0.150 |
Why?
|
Amino Acid Substitution | 3 | 2022 | 1793 | 0.150 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 3 | 2014 | 82 | 0.150 |
Why?
|
Young Adult | 17 | 2024 | 56429 | 0.140 |
Why?
|
Models, Immunological | 1 | 2019 | 527 | 0.140 |
Why?
|
Sex Factors | 3 | 2021 | 10400 | 0.140 |
Why?
|
Viral Envelope Proteins | 2 | 2019 | 636 | 0.140 |
Why?
|
Interferon-gamma | 7 | 2020 | 3207 | 0.140 |
Why?
|
Proline | 4 | 2022 | 458 | 0.140 |
Why?
|
Gastrointestinal Tract | 1 | 2022 | 814 | 0.140 |
Why?
|
Parturition | 1 | 2020 | 441 | 0.140 |
Why?
|
RNA Virus Infections | 1 | 2015 | 17 | 0.140 |
Why?
|
Alanine Transaminase | 4 | 2022 | 592 | 0.130 |
Why?
|
Host-Pathogen Interactions | 2 | 2022 | 1480 | 0.130 |
Why?
|
Receptors, Fc | 1 | 2019 | 541 | 0.130 |
Why?
|
Interleukin-18 | 1 | 2017 | 249 | 0.130 |
Why?
|
T-Lymphocytes, Cytotoxic | 3 | 2011 | 1821 | 0.130 |
Why?
|
HLA Antigens | 3 | 2013 | 1382 | 0.130 |
Why?
|
Natural Cytotoxicity Triggering Receptor 1 | 2 | 2014 | 27 | 0.130 |
Why?
|
Uridine Monophosphate | 1 | 2015 | 70 | 0.130 |
Why?
|
B-Lymphocyte Subsets | 1 | 2016 | 246 | 0.130 |
Why?
|
Protease Inhibitors | 2 | 2009 | 791 | 0.130 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 2 | 2014 | 91 | 0.120 |
Why?
|
Th1 Cells | 1 | 2020 | 1057 | 0.120 |
Why?
|
Cryoglobulins | 1 | 2014 | 59 | 0.120 |
Why?
|
Leukocytes, Mononuclear | 3 | 2019 | 1837 | 0.120 |
Why?
|
Staining and Labeling | 1 | 2019 | 1101 | 0.120 |
Why?
|
Fluorenes | 1 | 2015 | 160 | 0.120 |
Why?
|
Chronic Disease | 8 | 2019 | 9145 | 0.120 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1790 | 0.120 |
Why?
|
Up-Regulation | 3 | 2021 | 4222 | 0.120 |
Why?
|
Bystander Effect | 1 | 2014 | 81 | 0.120 |
Why?
|
Interferon Type I | 1 | 2017 | 542 | 0.120 |
Why?
|
Cytokines | 6 | 2022 | 7323 | 0.120 |
Why?
|
Aged | 21 | 2024 | 163288 | 0.120 |
Why?
|
CA-125 Antigen | 1 | 2016 | 286 | 0.120 |
Why?
|
Liver Transplantation | 2 | 2021 | 2119 | 0.110 |
Why?
|
Gene Expression | 3 | 2022 | 7798 | 0.110 |
Why?
|
Cell Culture Techniques | 2 | 2019 | 1678 | 0.110 |
Why?
|
Viral Proteins | 5 | 2019 | 1900 | 0.110 |
Why?
|
Cross Infection | 2 | 2015 | 1417 | 0.110 |
Why?
|
Apyrase | 1 | 2015 | 364 | 0.110 |
Why?
|
Mutation | 11 | 2019 | 29786 | 0.110 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 2007 | 1085 | 0.110 |
Why?
|
Peptides | 3 | 2019 | 4410 | 0.110 |
Why?
|
Hepatitis B e Antigens | 2 | 2023 | 133 | 0.110 |
Why?
|
Polysaccharides | 1 | 2019 | 1059 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 3873 | 0.100 |
Why?
|
Bone Substitutes | 1 | 2014 | 229 | 0.100 |
Why?
|
Epidemics | 2 | 2016 | 523 | 0.100 |
Why?
|
Immunoglobulin G | 3 | 2019 | 4561 | 0.100 |
Why?
|
Biopsy | 3 | 2022 | 6755 | 0.100 |
Why?
|
Thermus | 1 | 1991 | 11 | 0.100 |
Why?
|
Aspirin | 1 | 2024 | 3283 | 0.100 |
Why?
|
Epitope Mapping | 2 | 2017 | 311 | 0.100 |
Why?
|
Genetic Variation | 4 | 2019 | 6542 | 0.100 |
Why?
|
DNA Ligases | 1 | 1991 | 80 | 0.100 |
Why?
|
Natural Cytotoxicity Triggering Receptor 3 | 1 | 2010 | 11 | 0.100 |
Why?
|
Suppression, Genetic | 1 | 2011 | 196 | 0.100 |
Why?
|
DNA, Viral | 4 | 2023 | 2227 | 0.100 |
Why?
|
Fibrosis | 3 | 2022 | 2029 | 0.100 |
Why?
|
Lymphocyte Count | 2 | 2010 | 793 | 0.100 |
Why?
|
Drug Therapy, Combination | 4 | 2019 | 6489 | 0.090 |
Why?
|
Fluorescent Dyes | 1 | 2019 | 1917 | 0.090 |
Why?
|
2-Naphthylamine | 2 | 2021 | 23 | 0.090 |
Why?
|
Antibodies, Monoclonal | 2 | 2019 | 9274 | 0.090 |
Why?
|
HLA-C Antigens | 1 | 2010 | 147 | 0.090 |
Why?
|
Receptors, KIR | 1 | 2010 | 113 | 0.090 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2006 | 985 | 0.090 |
Why?
|
Amino Acid Sequence | 7 | 2017 | 13814 | 0.090 |
Why?
|
Cluster Analysis | 1 | 2017 | 2715 | 0.090 |
Why?
|
Benzimidazoles | 1 | 2015 | 850 | 0.090 |
Why?
|
Osteonectin | 1 | 2009 | 34 | 0.090 |
Why?
|
Vasculitis | 1 | 2014 | 519 | 0.090 |
Why?
|
Placenta | 1 | 2019 | 1699 | 0.090 |
Why?
|
Interleukin-2 | 2 | 2020 | 1904 | 0.090 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1340 | 0.090 |
Why?
|
Interleukin-7 Receptor alpha Subunit | 1 | 2009 | 52 | 0.090 |
Why?
|
Cohort Studies | 10 | 2019 | 40559 | 0.090 |
Why?
|
Trabecular Meshwork | 1 | 2009 | 99 | 0.090 |
Why?
|
Down-Regulation | 2 | 2021 | 3001 | 0.090 |
Why?
|
North America | 3 | 2017 | 1249 | 0.080 |
Why?
|
Uracil | 2 | 2021 | 165 | 0.080 |
Why?
|
HIV Antibodies | 1 | 2016 | 1322 | 0.080 |
Why?
|
K562 Cells | 1 | 2010 | 635 | 0.080 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1707 | 0.080 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2014 | 496 | 0.080 |
Why?
|
Hemodialysis Units, Hospital | 1 | 2008 | 22 | 0.080 |
Why?
|
Cyclopropanes | 2 | 2021 | 416 | 0.080 |
Why?
|
Cross Reactions | 3 | 2019 | 841 | 0.080 |
Why?
|
Clinical Enzyme Tests | 1 | 2008 | 115 | 0.080 |
Why?
|
Lactams, Macrocyclic | 2 | 2021 | 320 | 0.080 |
Why?
|
Immunity, Mucosal | 1 | 2011 | 490 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2026 | 0.080 |
Why?
|
Osteopontin | 1 | 2009 | 294 | 0.080 |
Why?
|
Virus Diseases | 1 | 2014 | 711 | 0.080 |
Why?
|
Australia | 3 | 2016 | 1167 | 0.080 |
Why?
|
Case-Control Studies | 4 | 2014 | 21748 | 0.080 |
Why?
|
Membrane Proteins | 2 | 2016 | 7882 | 0.080 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 3646 | 0.080 |
Why?
|
Membrane Transport Proteins | 1 | 2013 | 1031 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2024 | 2214 | 0.070 |
Why?
|
Receptors, Immunologic | 1 | 2013 | 1423 | 0.070 |
Why?
|
Tissue Scaffolds | 1 | 2014 | 956 | 0.070 |
Why?
|
Hepatocytes | 1 | 2014 | 1211 | 0.070 |
Why?
|
Disease Models, Animal | 6 | 2016 | 18034 | 0.070 |
Why?
|
Antibody Affinity | 2 | 2019 | 254 | 0.070 |
Why?
|
Orthomyxoviridae | 1 | 2008 | 156 | 0.070 |
Why?
|
Viral Core Proteins | 1 | 2006 | 162 | 0.070 |
Why?
|
Sex Characteristics | 1 | 2016 | 2585 | 0.070 |
Why?
|
Incidence | 6 | 2018 | 20952 | 0.070 |
Why?
|
Disease Progression | 3 | 2021 | 13286 | 0.070 |
Why?
|
Bacterial Infections | 1 | 2014 | 1401 | 0.070 |
Why?
|
Adolescent | 9 | 2024 | 85779 | 0.070 |
Why?
|
HLA-B8 Antigen | 1 | 2004 | 19 | 0.060 |
Why?
|
HLA-DR Antigens | 2 | 2005 | 645 | 0.060 |
Why?
|
Lymphocytic choriomeningitis virus | 2 | 2016 | 168 | 0.060 |
Why?
|
Th17 Cells | 1 | 2011 | 766 | 0.060 |
Why?
|
Immunophenotyping | 2 | 2014 | 1880 | 0.060 |
Why?
|
Genome-Wide Association Study | 6 | 2022 | 12262 | 0.060 |
Why?
|
Macrocyclic Compounds | 2 | 2019 | 72 | 0.060 |
Why?
|
Glycosylation | 2 | 2019 | 1128 | 0.060 |
Why?
|
Cells, Cultured | 2 | 2019 | 19233 | 0.060 |
Why?
|
Animals | 16 | 2023 | 168768 | 0.060 |
Why?
|
Liver Neoplasms | 2 | 2024 | 4253 | 0.060 |
Why?
|
Prospective Studies | 11 | 2020 | 53290 | 0.060 |
Why?
|
Immunohistochemistry | 4 | 2009 | 11366 | 0.060 |
Why?
|
Tissue Engineering | 1 | 2014 | 1880 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12244 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2016 | 3966 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9445 | 0.060 |
Why?
|
Risk-Taking | 1 | 2009 | 986 | 0.060 |
Why?
|
Recombinant Proteins | 3 | 2010 | 6621 | 0.060 |
Why?
|
Time Factors | 5 | 2017 | 40075 | 0.060 |
Why?
|
B-Lymphocytes | 1 | 2016 | 4666 | 0.050 |
Why?
|
Collagen | 2 | 2022 | 2688 | 0.050 |
Why?
|
Zambia | 1 | 2023 | 261 | 0.050 |
Why?
|
Protein Isoforms | 2 | 2022 | 1730 | 0.050 |
Why?
|
Communicable Disease Control | 1 | 2009 | 856 | 0.050 |
Why?
|
Pilot Projects | 3 | 2015 | 8319 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2011 | 2566 | 0.050 |
Why?
|
Hepatitis B Core Antigens | 1 | 2022 | 92 | 0.050 |
Why?
|
HLA-A2 Antigen | 1 | 2002 | 213 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2016 | 3921 | 0.050 |
Why?
|
Hepatitis B Antibodies | 1 | 2022 | 159 | 0.050 |
Why?
|
Septins | 1 | 2021 | 52 | 0.050 |
Why?
|
Sequence Analysis, DNA | 4 | 2016 | 4805 | 0.050 |
Why?
|
Brazil | 3 | 2011 | 1270 | 0.050 |
Why?
|
Follow-Up Studies | 7 | 2024 | 39052 | 0.050 |
Why?
|
Nucleosides | 1 | 2021 | 138 | 0.050 |
Why?
|
Massachusetts | 2 | 2015 | 8662 | 0.050 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2022 | 305 | 0.050 |
Why?
|
Organotechnetium Compounds | 1 | 2000 | 137 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2019 | 3595 | 0.050 |
Why?
|
High Mobility Group Proteins | 1 | 2021 | 187 | 0.050 |
Why?
|
Palate | 1 | 2001 | 123 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2017 | 63107 | 0.050 |
Why?
|
Sulfonamides | 2 | 2021 | 1940 | 0.050 |
Why?
|
Europe | 2 | 2017 | 3338 | 0.050 |
Why?
|
Leucine | 1 | 2022 | 560 | 0.050 |
Why?
|
Alleles | 3 | 2022 | 6933 | 0.050 |
Why?
|
Basement Membrane | 1 | 2001 | 357 | 0.040 |
Why?
|
End Stage Liver Disease | 1 | 2024 | 314 | 0.040 |
Why?
|
Receptor, IGF Type 1 | 1 | 2022 | 390 | 0.040 |
Why?
|
Polyethylene Glycols | 1 | 2005 | 1182 | 0.040 |
Why?
|
Mandibular Neoplasms | 1 | 2000 | 129 | 0.040 |
Why?
|
Valine | 1 | 2021 | 413 | 0.040 |
Why?
|
Lipids | 1 | 2011 | 3307 | 0.040 |
Why?
|
Ritonavir | 1 | 2021 | 322 | 0.040 |
Why?
|
Belgium | 1 | 2019 | 103 | 0.040 |
Why?
|
Immunoenzyme Techniques | 2 | 2001 | 1799 | 0.040 |
Why?
|
Keratins | 1 | 2001 | 515 | 0.040 |
Why?
|
Laminin | 1 | 2001 | 419 | 0.040 |
Why?
|
Obesity | 1 | 2021 | 12746 | 0.040 |
Why?
|
Ribosomal Proteins | 1 | 2021 | 360 | 0.040 |
Why?
|
Genes, MHC Class II | 2 | 2014 | 457 | 0.040 |
Why?
|
Connective Tissue | 1 | 2001 | 420 | 0.040 |
Why?
|
Cell Degranulation | 1 | 2019 | 287 | 0.040 |
Why?
|
Anilides | 1 | 2021 | 408 | 0.040 |
Why?
|
Coloring Agents | 1 | 2001 | 566 | 0.040 |
Why?
|
Cell Proliferation | 2 | 2012 | 10483 | 0.040 |
Why?
|
Molecular Sequence Data | 6 | 2007 | 18111 | 0.040 |
Why?
|
Biopsy, Fine-Needle | 1 | 2023 | 1094 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2006 | 3773 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2014 | 8432 | 0.040 |
Why?
|
Gene Frequency | 2 | 2016 | 3587 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2013 | 15078 | 0.040 |
Why?
|
Dengue Virus | 1 | 2019 | 204 | 0.040 |
Why?
|
Extracellular Matrix Proteins | 1 | 2022 | 850 | 0.040 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 627 | 0.040 |
Why?
|
Chromatin | 2 | 2021 | 2933 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3751 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 7914 | 0.040 |
Why?
|
Phylogeography | 1 | 2016 | 82 | 0.040 |
Why?
|
Keratinocytes | 1 | 2001 | 799 | 0.040 |
Why?
|
Binding Sites | 2 | 2019 | 6111 | 0.040 |
Why?
|
Blood Donors | 1 | 2019 | 355 | 0.040 |
Why?
|
Lost to Follow-Up | 1 | 2017 | 105 | 0.040 |
Why?
|
Dengue | 1 | 2019 | 256 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2013 | 4257 | 0.030 |
Why?
|
Mice | 7 | 2022 | 81201 | 0.030 |
Why?
|
Epithelium | 1 | 2001 | 1679 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17446 | 0.030 |
Why?
|
Diphosphonates | 1 | 2000 | 623 | 0.030 |
Why?
|
Receptors, IgG | 1 | 2019 | 582 | 0.030 |
Why?
|
Arenaviridae Infections | 1 | 2015 | 51 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2001 | 2124 | 0.030 |
Why?
|
Mice, Inbred C57BL | 4 | 2016 | 21833 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 2006 | 2751 | 0.030 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2004 | 2232 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2000 | 1107 | 0.030 |
Why?
|
Population Surveillance | 2 | 2017 | 2616 | 0.030 |
Why?
|
Mouth Neoplasms | 1 | 2000 | 601 | 0.030 |
Why?
|
Cell Line | 1 | 2009 | 16000 | 0.030 |
Why?
|
Dioxygenases | 1 | 2017 | 316 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2023 | 2012 | 0.030 |
Why?
|
SOXB1 Transcription Factors | 1 | 2016 | 284 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2016 | 500 | 0.030 |
Why?
|
Molecular Epidemiology | 1 | 2016 | 468 | 0.030 |
Why?
|
Mucus | 1 | 2016 | 321 | 0.030 |
Why?
|
Chemokines | 1 | 2019 | 970 | 0.030 |
Why?
|
Hydroxyapatites | 1 | 2014 | 75 | 0.030 |
Why?
|
Risk Factors | 6 | 2021 | 72296 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2022 | 2016 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2022 | 2076 | 0.030 |
Why?
|
Perforin | 1 | 2014 | 168 | 0.030 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2016 | 279 | 0.030 |
Why?
|
Cryoglobulinemia | 1 | 2014 | 87 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2022 | 4424 | 0.030 |
Why?
|
Bone Matrix | 1 | 2014 | 118 | 0.030 |
Why?
|
Ceramics | 1 | 2014 | 105 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 2017 | 1247 | 0.030 |
Why?
|
Evolution, Molecular | 3 | 2007 | 1939 | 0.030 |
Why?
|
Interleukin-4 | 1 | 1997 | 1147 | 0.030 |
Why?
|
Plasma | 1 | 2016 | 575 | 0.030 |
Why?
|
Cell Line, Tumor | 3 | 2019 | 16690 | 0.030 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2014 | 380 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2004 | 2725 | 0.030 |
Why?
|
Risk Assessment | 2 | 2017 | 23336 | 0.030 |
Why?
|
STAT1 Transcription Factor | 1 | 2014 | 320 | 0.030 |
Why?
|
Alveolar Process | 1 | 2014 | 293 | 0.030 |
Why?
|
Antigen Presentation | 2 | 2011 | 1284 | 0.030 |
Why?
|
Antibodies | 1 | 2001 | 2460 | 0.030 |
Why?
|
Gene Dosage | 1 | 2017 | 1252 | 0.030 |
Why?
|
Mucous Membrane | 1 | 2016 | 673 | 0.030 |
Why?
|
Rats, Inbred Lew | 1 | 2014 | 1162 | 0.030 |
Why?
|
Inflammasomes | 1 | 2017 | 495 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2015 | 1572 | 0.030 |
Why?
|
Prognosis | 2 | 2013 | 29060 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2014 | 844 | 0.020 |
Why?
|
Cytomegalovirus | 2 | 2008 | 733 | 0.020 |
Why?
|
Seroepidemiologic Studies | 1 | 2013 | 402 | 0.020 |
Why?
|
Interleukin-10 | 1 | 1997 | 1200 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2018 | 1222 | 0.020 |
Why?
|
Maxilla | 1 | 2014 | 471 | 0.020 |
Why?
|
Cloning, Molecular | 2 | 1991 | 4320 | 0.020 |
Why?
|
Vagina | 1 | 2016 | 825 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2000 | 2645 | 0.020 |
Why?
|
Biological Evolution | 1 | 2016 | 1077 | 0.020 |
Why?
|
United States | 5 | 2019 | 69872 | 0.020 |
Why?
|
Cell Separation | 1 | 2016 | 1751 | 0.020 |
Why?
|
Genes, p53 | 1 | 1993 | 755 | 0.020 |
Why?
|
Logistic Models | 2 | 2017 | 13409 | 0.020 |
Why?
|
Sampling Studies | 1 | 2011 | 623 | 0.020 |
Why?
|
Base Sequence | 3 | 2007 | 12797 | 0.020 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2014 | 450 | 0.020 |
Why?
|
Genes, ras | 1 | 1993 | 690 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 25039 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12025 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 2 | 2007 | 2560 | 0.020 |
Why?
|
Wound Healing | 1 | 2001 | 2785 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 15160 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2002 | 5096 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2014 | 739 | 0.020 |
Why?
|
Random Allocation | 1 | 2014 | 2428 | 0.020 |
Why?
|
Phenylthiourea | 1 | 2008 | 11 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2011 | 2540 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2001 | 3690 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2019 | 3177 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2017 | 1580 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2016 | 2307 | 0.020 |
Why?
|
Osteoblasts | 1 | 2014 | 1166 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2014 | 14561 | 0.020 |
Why?
|
HIV | 2 | 2008 | 1604 | 0.020 |
Why?
|
Netherlands | 1 | 2012 | 2170 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 2003 | 4251 | 0.020 |
Why?
|
Pregnancy | 2 | 2020 | 29144 | 0.020 |
Why?
|
Lipoproteins, LDL | 1 | 2011 | 640 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2504 | 0.020 |
Why?
|
Neuraminidase | 1 | 2008 | 210 | 0.020 |
Why?
|
Blotting, Western | 2 | 2011 | 5181 | 0.020 |
Why?
|
Canada | 1 | 2012 | 2065 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2505 | 0.020 |
Why?
|
Carbamates | 1 | 2008 | 196 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2000 | 4042 | 0.020 |
Why?
|
Viral Matrix Proteins | 1 | 2008 | 186 | 0.020 |
Why?
|
Macrophages | 1 | 2022 | 5660 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2010 | 57776 | 0.020 |
Why?
|
Vaccines, Synthetic | 1 | 2010 | 634 | 0.020 |
Why?
|
Vaccination | 1 | 2019 | 3279 | 0.020 |
Why?
|
Osteogenesis | 1 | 2014 | 1299 | 0.020 |
Why?
|
Serotyping | 1 | 2007 | 338 | 0.020 |
Why?
|
Consensus Sequence | 1 | 2007 | 378 | 0.020 |
Why?
|
Genes, MHC Class I | 1 | 2007 | 258 | 0.020 |
Why?
|
HIV Core Protein p24 | 1 | 2006 | 256 | 0.020 |
Why?
|
Lipoproteins, HDL | 1 | 2011 | 638 | 0.020 |
Why?
|
Models, Molecular | 1 | 2017 | 5451 | 0.020 |
Why?
|
DNA, Bacterial | 1 | 1991 | 1465 | 0.020 |
Why?
|
Comorbidity | 2 | 2014 | 10388 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2015 | 1771 | 0.020 |
Why?
|
5' Untranslated Regions | 1 | 2007 | 249 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2019 | 25628 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2008 | 644 | 0.020 |
Why?
|
Fetal Blood | 1 | 2011 | 1318 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2000 | 4034 | 0.020 |
Why?
|
Temperature | 1 | 1991 | 2204 | 0.020 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2007 | 323 | 0.020 |
Why?
|
Agammaglobulinemia | 1 | 2006 | 167 | 0.020 |
Why?
|
Escherichia coli | 2 | 1991 | 4217 | 0.020 |
Why?
|
Prevalence | 1 | 2001 | 15221 | 0.020 |
Why?
|
Program Evaluation | 1 | 2013 | 2488 | 0.010 |
Why?
|
Cholesterol, HDL | 1 | 2011 | 1813 | 0.010 |
Why?
|
Pan troglodytes | 1 | 2004 | 229 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2004 | 329 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2016 | 9735 | 0.010 |
Why?
|
Quinolines | 1 | 2008 | 732 | 0.010 |
Why?
|
Protein Binding | 1 | 2016 | 9384 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2000 | 8949 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3677 | 0.010 |
Why?
|
Mesenchymal Stem Cells | 1 | 2014 | 1632 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2007 | 6171 | 0.010 |
Why?
|
Oligopeptides | 1 | 2008 | 1189 | 0.010 |
Why?
|
Immunoassay | 1 | 2006 | 752 | 0.010 |
Why?
|
Triglycerides | 1 | 2011 | 2453 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5717 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2007 | 2256 | 0.010 |
Why?
|
Histocompatibility Testing | 1 | 2004 | 741 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2007 | 2839 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2013 | 4328 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
HIV Seropositivity | 1 | 2008 | 971 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2011 | 14723 | 0.010 |
Why?
|
Self Report | 1 | 2013 | 3553 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4554 | 0.010 |
Why?
|
Cell Count | 1 | 2006 | 1856 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10943 | 0.010 |
Why?
|
Thiazoles | 1 | 2008 | 1483 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2355 | 0.010 |
Why?
|
Amino Acids | 1 | 2007 | 1737 | 0.010 |
Why?
|
Selection, Genetic | 1 | 2006 | 914 | 0.010 |
Why?
|
Radiography, Panoramic | 1 | 2000 | 115 | 0.010 |
Why?
|
Immunoglobulins | 1 | 2004 | 881 | 0.010 |
Why?
|
Infection Control | 1 | 2008 | 965 | 0.010 |
Why?
|
HeLa Cells | 1 | 2006 | 3130 | 0.010 |
Why?
|
Cell Division | 1 | 2008 | 4569 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2011 | 13035 | 0.010 |
Why?
|
DNA, Recombinant | 1 | 1980 | 476 | 0.010 |
Why?
|
Stem Cells | 1 | 2012 | 3567 | 0.010 |
Why?
|
Globins | 1 | 1980 | 416 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2008 | 2265 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2006 | 6386 | 0.010 |
Why?
|
Rats | 1 | 2014 | 24252 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2001 | 805 | 0.010 |
Why?
|
Cytomegalovirus Infections | 1 | 2004 | 820 | 0.010 |
Why?
|
Mass Screening | 1 | 2013 | 5253 | 0.010 |
Why?
|
Genes | 1 | 1980 | 1893 | 0.010 |
Why?
|
Mandible | 1 | 2000 | 740 | 0.010 |
Why?
|
Coronary Disease | 1 | 2011 | 6077 | 0.010 |
Why?
|
Genetic Testing | 1 | 2008 | 3444 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15535 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 1993 | 5263 | 0.010 |
Why?
|
Patient Care Planning | 1 | 2000 | 921 | 0.010 |
Why?
|
Recurrence | 1 | 2006 | 8340 | 0.010 |
Why?
|
Observer Variation | 1 | 2000 | 2593 | 0.010 |
Why?
|
Inflammation | 1 | 2014 | 10637 | 0.010 |
Why?
|
Transcription Factors | 1 | 2014 | 12207 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3771 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2015 | 77460 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2000 | 3616 | 0.010 |
Why?
|
Th2 Cells | 1 | 1997 | 1061 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2008 | 7282 | 0.010 |
Why?
|
Point Mutation | 1 | 1993 | 1624 | 0.000 |
Why?
|
RNA | 1 | 1997 | 2749 | 0.000 |
Why?
|
Pancreas | 1 | 1993 | 1687 | 0.000 |
Why?
|
Tumor Cells, Cultured | 1 | 1993 | 6313 | 0.000 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 1993 | 2949 | 0.000 |
Why?
|
DNA Restriction Enzymes | 1 | 1980 | 570 | 0.000 |
Why?
|
Lac Operon | 1 | 1980 | 238 | 0.000 |
Why?
|
beta-Galactosidase | 1 | 1980 | 574 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2000 | 20130 | 0.000 |
Why?
|
Plasmids | 1 | 1980 | 2308 | 0.000 |
Why?
|
Rabbits | 1 | 1980 | 4894 | 0.000 |
Why?
|